Kung MP - Search Results

1

Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography.

Mach RH, Nader MA, Ehrenkaufer RL, Line SW, Smith CR, Luedtke RR, Kung MP, Kung HF, Lyons D, Morton TE. Mach RH, et al. Among authors: kung hf, kung mp. Synapse. 1996 Dec;24(4):322-33. doi: 10.1002/(SICI)1098-2396(199612)24:4<322::AID-SYN2>3.0.CO;2-F. Synapse. 1996. PMID: 10638823

2

In vivo binding of [123I]4-(2'-methoxyphenyl)-1-[2'-(N-2"-pyridinyl)- p-iodobenzamido-]ethyl-piperazine, p-MPPI, to 5-HT1A receptors in rat brain.

Kung MP, Zhuang ZP, Frederick D, Kung HF. Kung MP, et al. Among authors: kung hf. Synapse. 1994 Dec;18(4):359-66. doi: 10.1002/syn.890180412. Synapse. 1994. PMID: 7886629

3

Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT.

Chumpradit S, Kung MP, Billings J, Mach R, Kung HF. Chumpradit S, et al. Among authors: kung hf, kung mp. J Med Chem. 1993 Jan 22;36(2):221-8. doi: 10.1021/jm00054a005. J Med Chem. 1993. PMID: 8093734

4

P-[18F]-MPPF: a potential radioligand for PET studies of 5-HT1A receptors in humans.

Shiue CY, Shiue GG, Mozley PD, Kung MP, Zhuang ZP, Kim HJ, Kung HF. Shiue CY, et al. Among authors: kung hf, kung mp. Synapse. 1997 Feb;25(2):147-54. doi: 10.1002/(SICI)1098-2396(199702)25:2<147::AID-SYN5>3.0.CO;2-C. Synapse. 1997. PMID: 9021895

5

Radiopharmaceuticals for single-photon emission computed tomography brain imaging.

Kung HF, Kung MP, Choi SR. Kung HF, et al. Among authors: kung mp. Semin Nucl Med. 2003 Jan;33(1):2-13. doi: 10.1053/snuc.2003.127296. Semin Nucl Med. 2003. PMID: 12605353 Review.

6

Synthesis and characterization of iodobenzamide analogues: potential D-2 dopamine receptor imaging agents.

Murphy RA, Kung HF, Kung MP, Billings J. Murphy RA, et al. Among authors: kung hf, kung mp. J Med Chem. 1990 Jan;33(1):171-8. doi: 10.1021/jm00163a029. J Med Chem. 1990. PMID: 2136916

7

In vivo SPECT imaging of CNS D-2 dopamine receptors: initial studies with iodine-123-IBZM in humans.

Kung HF, Alavi A, Chang W, Kung MP, Keyes JW Jr, Velchik MG, Billings J, Pan S, Noto R, Rausch, et al. Kung HF, et al. Among authors: kung mp. J Nucl Med. 1990 May;31(5):573-9. J Nucl Med. 1990. PMID: 2140408 Free article.

8

The characterization of IBF as a new selective dopamine D-2 receptor imaging agent.

Kung MP, Kung HF, Billings J, Yang Y, Murphy RA, Alavi A. Kung MP, et al. Among authors: kung hf. J Nucl Med. 1990 May;31(5):648-54. J Nucl Med. 1990. PMID: 2140409 Free article.

9

Current and future radiopharmaceuticals for brain imaging with single photon emission computed tomography.

Kung HF, Ohmomo Y, Kung MP. Kung HF, et al. Among authors: kung mp. Semin Nucl Med. 1990 Oct;20(4):290-302. doi: 10.1016/s0001-2998(05)80235-1. Semin Nucl Med. 1990. PMID: 2237449 Review.

10

In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.

Kung HF, Pan S, Kung MP, Billings J, Kasliwal R, Reilley J, Alavi A. Kung HF, et al. Among authors: kung mp. J Nucl Med. 1989 Jan;30(1):88-92. J Nucl Med. 1989. PMID: 2783457 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters